Department of Pharmacology, Jichi Medical School, Tochigi 329-0498, Japan
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Stanniocalcin (STC) is a calcium- and phosphate-regulating hormone produced in bony fish by the corpuscles of Stannius, which are located close to the kidney. It is a major antihypercalcemic hormone in fish. As the corpuscles of Stannius are absent, and antihypercalcemic hormones are basically not necessary, in mammals, the discovery of a mammalian homolog, STC1, was surprising and intriguing. STC1 displays a relatively high amino acid sequence identity (~50%) with fish STC. In contrast to fish STC, STC1 is expressed in many tissues, including kidney. More recently, a human gene encoding the second stanniocalcin-like protein, STC2, was identified. STC2 has a lower identity (~35%) with STC1 and fish STC. Similar to STC1, STC2 is also expressed in a variety of tissues. Research into the functions of STCs in mammals is still at an early stage, and the ultimate physiological and pathological roles of STCs have not yet been established. A few studies indicate that STC1, similar to fish STC, stimulates phosphate absorption in the kidney and intestine, but the function of STC2 is still unknown. However, several interesting findings have been reported on their cellular localization, gene structure, and expression in different physiological and pathological conditions, which will be clues in elucidating the functions of STCs in mammals. STC1 expression is enhanced by hypertonicity in a kidney cell line or by ischemic injuries and neural differentiation in the brain. STC1 expression in the ovary is also enhanced during pregnancy and lactation. Calcitriol upregulates STC1 and downregulates STC2 expression in the kidney. Interestingly, STC1 and STC2 are expressed in many tumor cell lines, and the expression of STC2 is enhanced by estradiol in breast cancer cells. STC2 is also expressed in pancreatic islets. These results suggest that the biological repertoires of STCs in mammals will be considerably larger than in fish and may not be limited to mineral metabolism. This brief review describes recent progress in mammalian STC research.
phosphate transport; calcium homeostasis; hypertonicity; ischemia
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
STANNIOCALCIN (STC; previously named hypocalcin or teleocalcin) is a glycoprotein hormone that was thought to be unique to teleostean and holostean fish (reviewed in Ref. 1). STC is secreted by specialized organs, the corpuscles of Stannius (CS), which are located adjacent to the kidney or scattered throughout the kidney proper. CS cells may be derived from nephric ducts (24). One pair is found in most fish, and the removal of these glands produces hypercalcemia. Therefore, the main function of STC, similar to that of calcitonin, appears to be the prevention of hypercalcemia. In fish, both STC and calcitonin are antihypercalcemic, but the capacity of STC surpasses that of calcitonin. The main targets of STC are the entry routes of Ca: the gills and intestines. In seawater, where Ca2+ concentration is 40 mg/dl, which is 10 times higher than that of extracellular fluid, hypercalcemia is a continuous threat to the fish because Ca will enter the body by diffusion across the gills and skin as well as via the intestines. STC seems to prevent Ca entry from the gills and intestines (13, 38). The mechanism of this inhibition remains unclear. It is proposed that the decrease in cAMP by STC inhibits Ca channels at the gill epithelial cells (1). However, other investigators speculate that STC modulates the number and/or size of Ca-transporting cells but not the membrane density of Ca transporters (42). In the marine environment, with high Ca levels, STC was believed to play an important role in mineral homeostasis. However, even in freshwater fish, the Ca concentration of the surrounding water is higher than that in cells, so the regulation of Ca entry at the gills and intestines is important. In fact, there is no difference between freshwater and marine salmon in the blood level and sensitivity of STC to Ca (44). Moreover, the net Ca flux in freshwater fish is positive possibly by the active absorption of Ca from the intestine (13). Therefore, STC is an important regulator of Ca in both marine and freshwater fish. Interestingly, roles of STC other than Ca homeostasis are reported: phosphate homeostasis (25) and ovarian function (39). Presently, active research on fish STC continues because its receptor and signaling mechanisms have not yet been clarified.
In terrestrial animals, the primary hormone for the homeostatic control of extracellular Ca is parathyroid hormone (PTH). However, PTH is hypercalcemic whereas STC is antihypercalcemic. This difference may be caused by the fact that Ca concentrations in the bodily fluids of terrestrial animals are dependent on internal stores (bones) to prevent the constant threat of hypocalcemia. Therefore, the presence in terrestrial animals of STC homologs as antihypercalcemic hormones was doubted because they may be unnecessary for these animals, as terrestrial animals seldom face the threat of hypercalcemia and they do not spontaneously become hypercalcemic. Their plasma Ca concentrations increase only transiently after the ingestion of foods containing Ca. In response to such postprandial hypercalcemia, calcitonin is secreted to facilitate the net Ca transfer to bone to decrease plasma Ca concentration to a normal level. Moreover, no homologous organs for CS have been identified in higher vertebrates. However, some reports suggested the presence of a functional receptor for STC homologs because the injection of fish STC in frogs, birds, and rats induced hypocalcemia (26, 28, 36). More directly, it was reported that human kidney cells cross-reacted with anti-salmon STC antibody (43). The molecular identity of STC homologs in these animals and humans were unknown until the discovery of a mammalian homolog, STC1 (3, 4, 32).
It is possible that STC is conserved through the evolution of fish to
mammals and that STC homologs may also be present in amphibia,
reptilia, and birds. Presently, however, only mammalian STC homologs
have been identified. The role of STC homologs in terrestrial animals
seems to have changed through evolution. For example, STC1 seems to
have the effect more preferentially on phosphate metabolism than on Ca
metabolism: STC1 has been shown to stimulate phosphate reabsorption in
the small intestine and proximal tubules of the kidney (26,
46). Moreover, human STC1 expression is not limited to a single
organ but is expressed in many tissues, most abundantly in the ovary,
prostate, and thyroid gland (4, 32). Such a wide
expression pattern is also shown in mice (3) and rats
(Fig. 1), suggesting a paracrine rather than a classic endocrine role of STC1. Recent identification of the
second homolog (STC2) has introduced more complexity into this field.
This review will focus on STC2 and recent progress in our understanding
of the mammalian STC system.
|
![]() |
DISCOVERY OF THE SECOND GENE FOR MAMMALIAN STANNIOCALCIN |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
As only one STC is known in fish, it is somewhat surprising to
find the second gene for STC (STC2) in mammals. However, recent analyses of marine salmon and white suckers suggest that another STC
may also be present in fish (27, 45). Whether it is
similar to STC2 is presently unknown. The putative fish STC2 will
provide some clues to clarify the physiological role of STC2 in
mammals. The human STC2 cDNA was found by four independent
investigators based on the search for STC homologs in EST database
(6, 11, 19, 30). The presently known mammalian STCs are
aligned with two fish STCs (Fig. 2). STC2
is longer than STC1 and fish STC. STC2 has only ~35% identity with
both STC1 and fish STC, whereas STC1 has ~55% identity with fish
STC. Therefore, STC2, rather than STC1, is more distantly related to
fish STC. The NH2-terminal half of STC2 is cysteine rich,
suggesting that STC2 may also form dimers, as is the case with STC1 and
fish STC. Indeed, native hamster STC2 has been shown to form a
disulfide-linked homodimer with a subunit size of 35-40 kDa
(30). The sites of a consensus glycosylation sequence
[Asn-X-Thr(Ser)] are conserved among STCs, suggesting that STC2 is
also a glycoprotein and that the glycosylation is responsible for the
diffuse band in Western blots (30). Hydropathy profiles
indicate that the NH2 termini of STCs are hydrophobic and
may be the signal peptide sequences for secretory proteins. Thus the
first 24 amino acids of STC2 are cleaved off to produce a secretory
form, as shown in fish STC. In fish STC, the subsequent ~14 amino
acids are also cleaved off to produce a mature form. It is unknown at
present whether there is a prosegment in STC2 that would be cleaved off
to produce an active form. Hydropathy analyses of STC2, STC1, and fish
STC revealed that they share similar hydropathy profiles at the
NH2-terminal half but differ at the COOH-terminal half:
STC2 has a longer hydrophilic stretch at the COOH terminus. The COOH
terminus of STC2 also has a cluster of histidines (HHxxxxHH), which may
interact with divalent metal ions such as Zn, Co, Ni, and Cu. In fact,
this histidine cluster was used for binding STC2 to the Ni column to
purify STC2 (30). The functional significance of this
cluster remains to be clarified. The locations of 10 cysteines are
conserved among STCs (Fig. 2, ). However, at the COOH terminus, STC2
has four more cysteines than STC1 and fish STC. Moreover, the eleventh
cysteine conserved in STC1 and fish STC is not spatially conserved in
STC2 (Fig. 2, N). This cysteine appears to be important for the
disulfide-linked homodimer formation (18). Therefore, STC2
may undergo a different modification of its tertiary structure compared
with STC1 and fish STC. The presently known features of STC1 and STC2
are summarized in Table 1. As both STC1
and STC2 are widely expressed and their expressions overlap in some
tissues, it is conceivable that they form a heterodimer, as is the case
for activin and inhibin. They may be secreted by the same cells in some
tissues. In fact, a human fibrosarcoma cell line, HT1080, has been
shown to secrete both STC1 and STC2 as phosphoproteins in the medium
(21). However, it is not known whether STC1 and STC2 can
form heterodimers.
|
|
![]() |
STRUCTURE OF STANNIOCALCIN GENES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The genes for STC1 have been reported in humans, rats, and mice (5, 41). They are composed of four exons. Interestingly, they have CAG repeats at the 5'-untranslated region. Specifically, 33-bp additional CAG repeats were found in 2 of 198 chromosomes in humans. Although length polymorphisms such as CAG repeats are sometimes associated with the pathogenesis of diseases, as documented in Huntington's disease (35), the significance of CAG repeats in the STC1 gene is presently unknown. However, such a length polymorphism may be a clue in identifying individuals with different phenotypes due to putative different levels of STC1 gene expression.
In contrast, such CAG repeats are not found in the STC2 gene (19). Neither TATA boxlike sequences are found in the STC2 gene, although a TATA box is present in the STC1 gene. The STC2 gene is also composed of four exons, and the exon-intron boundaries are completely conserved between the STC2 and STC1 genes (19), suggesting that they were produced by gene duplication. However, the chromosomal locations of these genes are different in humans: STC1 is located at chromosome 8p11.2-p21 (5), whereas STC2 is located at chromosome 5q35 (47). Therefore, this gene duplication may be a relatively remote event. The chromosomal mappings of these genes await the analysis of their potential involvement in some genetic disorders. The identification of such diseases will reveal the function of human STCs.
![]() |
TISSUE DISTRIBUTION OF STANNIOCALCINS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
STC1 is widely expressed in humans and mice. However, among investigators, the major organs expressing STC1 detected by Northern blot differ. A recent report indicated high expression of 4-kb STC1 mRNA in humans in the thyroid gland, kidney and heart, with diminished expressions in the lung, placenta and trachea, but very little expression in the ovary (30). In contrast, others reported the highest expression of STC1 mRNA and protein in the ovary (4, 41, 49). Although the species difference may explain some of these differences, hormonal states may also affect the amount of STC1 expression in the ovary (49). In fact, STC1 expression in mouse ovary is regulated by gestation and lactation (10). In the ovary, STC1 mRNA is highly expressed at the secondary interstitial and the theca interna cells (10, 41). In bone, STC1 mRNA is expressed in osteoblasts and chondrocytes but not in osteoclasts (52). STC1 protein is also localized in developing bones and muscles of the fetal mouse (22). In the brain, the most intense staining was observed, with immunohistochemistry, in the pyramidal cells of the cerebral cortex and the hippocampus and in the Purkinje cells of the cerebellum (54). STC1 is also expressed in the choroid plexus (14). The expression of STC1 in brain neurons appears to be linked to their terminal differentiation: STC1 expression in human neural crest-derived tumor cells is enhanced after PMA-induced neural differentiation at both mRNA and protein levels, and strong STC1 expression was observed in fully differentiated large neurons but not in fetal and newborn mice (54). Interestingly, STC1 is expressed in many cancer cell lines and tumor tissues, including adrenal tumors (29). STC1 expression was even detected in blood samples from cancer patients (15). Some tissue injuries may shed endothelial cells into the circulation to complicate the results because normal vascular endothelial cells also express STC1 when stimulated (33). Therefore, the aforementioned results may not directly indicate that STC1 can be a molecular marker for the detection of tumor cells in the blood from patients with malignancies. Further studies are necessary to confirm this potentially important finding.
The results on STC1 localization in the kidney are controversial. The
presently available results are summarized in Table 2. STC1 gene expression was examined by
in situ hybridization and STC1 protein expression by
immunohistochemistry. Overall, STC1 is expressed in tubular epithelial
cells. As STC-producing cells in fish arise from pronephric/mesonephric
ducts (24), STC1 production in kidney epithelia may
indicate a common embryological origin of STC1 and fish STC. With
detailed analyses, however, it should be noted that there is a
discrepancy between STC1 mRNA and protein localization. In rat kidney,
the STC1 gene was expressed selectively in the collecting ducts,
specifically, in the principal cells and the -intercalated cells
(48). STC1 protein was also expressed in distal nephron
segments (16, 48). One report, however, showed STC1
protein expression in the proximal tubules (proximal straight tubules),
although in situ hybridization study of rat kidney failed to document
STC1 gene expression in the proximal tubules (48). A
similar discrepancy was noted in embryonic mouse kidneys
(37). Therefore, in rat and mouse kidneys, the STC1 gene
is expressed in distal segments, but STC1 protein is expressed in both
proximal and distal segments. Interestingly, STC1 protein in human
kidney appears to distribute similarly to the STC1 gene in rodent
kidney. Unfortunately, STC1 gene expression has not yet been examined
in human kidney. Curiously, in mouse kidney, STC1 gene was reported to
be expressed widely with less expression in the collecting ducts
(51). Another report on rat kidney failed to detect STC1
protein in the proximal tubules (16). At present, there is
no obvious way to reconcile these divergent observations.
|
It is noteworthy that a similar discrepancy between STC1 gene and protein expression has been reported in the ovary. STC1 immunostaining was intense in the oocyte cytoplasm and in some granulosa cells. However, both did not appear to express the STC1 gene (10). STC1 protein in these cells may be sequestrated from the surrounding primary theca. Alternatively, these cells may express the STC1 gene below the detection level of in situ hybridization. Therefore, care must be taken when STC1 expression is evaluated. For this reason, STC1 gene expression sites in the brain, muscle, and heart are still unknown because presently only immunohistochemical studies have been reported in these organs.
STC2 is also widely expressed. Two STC2 transcripts (2 and 4.4 kb) are present in different tissues: heart, placenta, lung, muscle, pancreas, and spleen (11, 30). However, much wider expression has been reported by other investigators (6, 19). It is possible that the STC2 expression pattern may reflect the different physiological states of factors that regulate its expression. In contrast to STC1, STC2 expression in the kidney is negligible, which suggests that STC2 may be derived from an unknown hormone secreted by organs other than CS in fish. Interestingly, the expression of 2.2- and 5-kb STC2 transcripts was reported in embryonic tissues of the kidney, lung, liver, and brain (11). Also reported was its expression in many tumor cell lines, with an especially high level in those from the lung, colon, and mammary glands, as well as in Hela cells. These tumor cell lines express an additional 4.3-kb transcript. As is the case with STC1, STC2 expression in embryos and tumor cell lines suggests its role in organogenesis and cell proliferation.
Presently, only one report is available on the cellular level of STC2
expression. Immunohistochemical studies revealed that STC2 is expressed
at -cells in pancreatic islets and colocalizes with
glucagon-secreting cells (30). This result agrees with the
relatively high level of STC2 mRNA expression in the pancreas (30). This provocative result suggests a role for STC2 in
glucose homeostasis.
![]() |
PHYSIOLOGICAL ROLES OF STANNIOCALCINS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The function of STC1 has only been partially clarified. We may expect more functions of STC1, as it is expressed in a wide range of tissues. Similarly, several functions of STC2 are also expected. However, our knowledge of its function is totally null. Therefore, one should be cautioned that what follows in this section will be highly speculative and that completely different views may be presented in the near future. STC1 and/or STC2 overproduction by transgenic animals and their inactivation in knockout mice by targeting disruption will reveal their unexpected functions.
Recombinant human STC1, when injected into rats, reduced renal phosphate excretion (46). This may be due to the stimulation of the phosphate transport in the proximal tubules, as the rate of Na-phosphate cotransport was 40% higher in vesicles from STC1-treated rats. However, the change in phosphate excretion in the urine by STC1 was marginal and not dose dependent. Moreover, the plasma phosphate concentration was not affected, suggesting that STC1 may not be the major determinant of the phosphate transporters. On the other hand, STC1 had no effect on Ca excretion in the urine and on plasma Ca concentration (46). Therefore, STC1 appears to participate in renal phosphate regulation and have little effect on Ca metabolism. However, the effect of STC1 on Ca metabolism in rats may be masked by PTH, a dominant regulator of extracellular Ca concentration. Furthermore, the interaction between PTH and STC1 may have complicated the results. For example, the NH2 terminus of fish STC inhibited the cAMP accumulation induced by PTH (50). If there is a similar interaction between STC1 and PTH, the effect of STC1 will be more pronounced in the absence of PTH. In fact, in vitro studies with pig and rat duodenal mucosa showed that administration of STC1 to the serosal surface reduced Ca absorption and stimulated phosphate absorption (26). These results suggest that the function of STC1 in mammals seems to be similar to that of fish STC. Because STC1 has 56-66% identity with fish STC, the conserved function of STC1 is not surprising. As STC1 expression in chondrocytes and osteoblasts has been shown (52), bone may also be an important target for STC1 in mammals. The effect of STC1 on bone is the most promising area for studying the function of STC1. Moreover, if the cellular uptake of phosphate in tumor cells is also enhanced by STC1, as shown in kidney proximal tubular cells, high STC1 expression in tumor cells may reflect a higher metabolic demand for phosphate in these cells, with STC1 acting in a paracrine/autocrine manner. On the other hand, it is unknown whether STC1 inhibits the cellular uptake of Ca as does fish STC in the gills. If STC1 has such a function, inhibition of Ca entry into cells by STC1 may protect them under the stress of hypertonicity or ischemia (34, 53). This issue will be discussed later.
As STC2 has only ~34% identity with STC1 and fish STC, the biological activities of STC2 may not be the same as those of STC1 and fish STC. Presently, only an indirect effect of STC2 on the kidney phosphate transporter was examined (19). The culture medium of STC2-transfected Chinese hamster ovary cells inhibited the promoter activity of the type II Na-phosphate cotransporter by 38%. Such an inhibitory effect on the type II Na-phosphate transporter accounts for the 26% reduction of phosphate uptake by a kidney cell line (opossum kidney cells). As the type II Na-phosphate cotransporter is a major phosphate uptake mechanism of the apical membrane of the kidney proximal tubules, the results suggest that STC2 may inhibit phosphate transport on a long-term basis through the transcriptional control of the phosphate transporter. Therefore, STC1 and STC2 seem to have opposite effects on phosphate transport in the kidney. However, this result was indirect and should be considered with reservation until the direct effect of recombinant STC2 on kidney phosphate transport is examined. In HYP mice with hypophosphatemia, STC2 mRNA expressions in most of the tissues are downregulated, except in the spleen (19). The downregulation of STC2 expression in rat kidney by calcitriol is also reported (17). Moreover, a preliminary study reported the upregulation of STC2 mRNA expression in mouse kidney with the use of a high-phosphate diet (31). Hence, these results suggest, albeit indirectly, that STC2 may also play a role in phosphate metabolism. As STC2 was cloned from a human osteosarcoma cDNA library and its expression in bone was abundant in mice (19), STC2 may also play a role in bone metabolism, including Ca homeostasis.
![]() |
REGULATION OF STANNIOCALCIN EXPRESSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Fish STC is induced by a high-Ca environment. This is consistent with an antihypercalcemic effect of STC. Similarly, STC1 is also upregulated by an increase in ambient Ca concentration: the expression of STC1 abruptly increased at an incubated ionic Ca concentration of >5.4 mM in cultured cells (4). However, the threshold of Ca for this response was unphysiologically high. This may be due to the change in the threshold modulated by culture conditions such as osmolarity (34), although the mechanism that defines the threshold has not been clarified. STC1 gene induction may be due to the increased ambient Ca concentration detected by sensors like the Ca-sensing receptor. In the culture condition, it is possible that there is a progressive decline in the number of putative Ca-sensing receptors per cell, resulting in the diminished cell sensitivity and responsiveness to Ca reported in PTH cells (2). Alternatively, STC1 gene induction may be due to the increase in intracellular Ca concentration, as the Ca ionophore was shown to stimulate fish STC secretion. Similarly, the upregulation of STC1 expression by calcitriol in the kidney (17) may well be due to a high serum Ca concentration, although it is also possible that calcitriol directly stimulated STC1 expression. The increase in STC1 mRNA may also be due to the enhanced stability of the STC1 transcript, as ambient high Ca has been shown to stabilize the transcript of STC in primary cultured cells from trout CS (12).
Of particular interest, STC1 expression in Madin-Darby canine kidney cells was also induced by hypertonicity, suggesting the role of STC1 in osmoregulation (34). STC1 expression was also stimulated in rat kidney by dehydration (Ishibashi K, unpublished observations). It is unknown whether the effect of osmolarity on STC1 expression is specific to the kidney or a more general phenomenon. In fact, the role of fish STC in water balance was suggested: stanniectomy has been shown to enhance the drinking rate in eels (40), and plasma osmolarity was decreased in stanniectomized fish (1). Therefore, further studies are warranted on the role of STC1 in water metabolism.
In neural cells, hypoxia induces STC1 (53), which may stimulate phosphate uptake by these cells through a paracrine/autocrine mechanism as is the case in kidney proximal tubules. Phosphate may buffer the toxic high intracellular free Ca and stimulate ATP synthesis in a hypoxic environment. Alternatively, STC1 may inhibit cytotoxic Ca entry into the cells in the ischemic condition, as fish STC inhibits Ca entry into the epithelial cells in gills. A dramatic induction of STC1 was also reported in human umbilical vein endothelial cells by lysophosphatidylcholine, a proatherogenic factor (33). A similar induction of the STC1 gene was also reported in serum-stimulated fibroblasts (20). These results suggest the role of STC1 in wound healing, possibly by mediating inflammation and/or angiogenesis (23). The mechanism of STC1 gene induction by hypoxia, hypertonicity, lysophosphatidylcholine, and serum is presently unclear but may be caused by the increase in intracellular Ca concentration. Whatever the mechanism, the transfection of STC1 to a neural crest-derived cell line (Paju cell) increased the resistance to the ischemic challenge, suggesting a beneficial therapeutic application of STC1 in some clinical settings (53). Clarification of its underlying resistance mechanism will reveal a novel function of STC1. A recent report on a blood-level assay of STC1, however, showed that STC1 does not normally circulate in the blood, having a short half-life and/or fast degradation (9), and that STC1 is detectable in the blood only during gestation (10). Hence, the mechanism of this degradation should be clarified before the therapeutic usage of STC1 is contemplated.
Reports on the regulation of the STC2 gene expression are more limited.
The downregulation of STC2 mRNA by calcitriol treatment and its
upregulation by a low-phosphate diet in mouse kidney were already
described above (17, 31). Interestingly, both STC1 and
STC2 expression are not affected by calcitriol in the ovary (17). The results suggest the tissue-specific regulation
of mammalian STCs or indirect effects of calcitriol on their gene expression. The results also suggest paracrine roles of mammalian STCs.
The researchers of mammalian STCs seem to be biased by the reports on
the function of fish STC, because the function of fish STC as a
regulator of mineral metabolism is relatively well established. However, the expression of fish STC is also modulated by factors seemingly unrelated to mineral metabolism. For example, estradiol increases fish STC, and prolactin induces the hypertrophy of CS (1). Neural regulation of STC release is also possible, as carbachol stimulates the production and release of fish STC
(1). Interestingly, STC2 expression was enhanced by
17-estradiol in estrogen receptor-positive breast cancer cells
(7). Potentially, STC2 may serve as a breast cancer
biomarker. More importantly, the role of STC2 in mammary gland
morphogenesis should be examined. Similarly, it was reported that
ovarian STC1 expression is enhanced during the estrous cycle, regulated
by luteinizing hormone and the high level of progesterone
(10). Furthermore, STC1 production in the ovary is
upregulated during lactation. Prolactin may stimulate this STC1
expression. Therefore, although it is highly speculative, mammary gland
development may be regulated by locally produced STC2 and distantly
produced STC1.
![]() |
CONCLUSIONS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Work in the last couple of years has provided molecular
identification and the first insights into the function of mammalian STCs. The present knowledge of the STC system in mammals is at a very
early stage. Its physiological functions are still unknown. Obviously,
further studies are required to clarify and establish the role of the
STC system in mammals. These include identification of cell types
producing STCs, the regulation of their expression in each cell and
each organ, the modes of action on specific cells through specific
receptor(s), the cloning of their receptor(s), and the signaling events
producing physiological effects and their physiological and
pathological functions. As the studies of the STC system in
fish become more advanced, the knowledge obtained from studies of fish
STC will definitely be beneficial in the research on the STC system in
mammals. However, as mammals have two STC isoforms and are devoid of
specialized organs that secrete STCs, it is anticipated that the STC
system in mammals deviates from that in fish. This system will provide
another dimension of the regulation of bone and mineral metabolism and
be a target for a therapeutic intervention in the treatment of
metabolic bone diseases. Moreover, its role in water metabolism should
be examined, as a recent report on stanniectomized eels showed
stimulated water intake and induction of STC1 in Madin-Darby canine
kidney cells by hypertonicity. Furthermore, a much wider biological
repertoire in this system is expected, as ischemic injuries
induced STC1 in mammalian brain and high STC2 expression at -cells
of the pancreatic islet. Clarification of the postulated protective
effect of the STC system against a high intracellular Ca concentration will lead to the development of new treatments for cellular injuries induced by inflammatory, ischemic, and hypertonic stresses.
Finally, as STCs are highly expressed in tumor cells and embryonic
organs, their roles in tumor biology and embryology should be clarified in the near future.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported in part by The Mochida Memorial Foundation for Medical and Pharmaceutical Research and by The Ryoichi Naito Foundation for Medical Research.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: K. Ishibashi, Dept. of Pharmacology, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan (E-mail: kishiba{at}jichi.ac.jp).
10.1152/ajprenal.00364.2000
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Bonga, SEW,
and
Pang PKT
Control of calcium regulating hormones in the vertebrates: parathyroid hormone, calcitonin, prolactin, and stanniocalcin.
Int Rev Cytol
128:
139-213,
1991[ISI][Medline].
2.
Brown, AJ,
Zhong M,
Ritter C,
Brown EM,
and
Slatopolsky E.
Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression.
Biochem Biophys Res Commun
212:
861-867,
1995[ISI][Medline].
3.
Chang, AC,
Dunham MA,
Jeffrey KJ,
and
Reddel RR.
Molecular cloning and characterization of mouse stanniocalcin cDNA.
Mol Cell Endocrinol
124:
185-187,
1996[ISI][Medline].
4.
Chang, AC,
Janosi J,
Hulsbeek M,
Jong D,
Jeffrey KJ,
Noble JR,
and
Reddel RR.
A novel human cDNA highly homologous to the fish hormone stanniocalcin.
Mol Cell Endocrinol
112:
241-247,
1995[ISI][Medline].
5.
Chang, AC,
Jeffrey KJ,
Tokutake Y,
Shimamoto A,
Neumann AA,
Dunham MA,
Cha J,
Sugawara M,
Furuichi Y,
and
Reddel RR.
Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats.
Genomics
47:
393-398,
1998[ISI][Medline].
6.
Chang, AC,
and
Reddel RR.
Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2.
Mol Cell Endocrinol
141:
95-99,
1998[ISI][Medline].
7.
Charpentier, AH,
Bednarek AK,
Daniel RL,
Hawkins KA,
Laflin KJ,
Gaddis S,
MacLeod MC,
and
Aldaz CM.
Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
Cancer Res
60:
5977-5983,
2000
8.
De Niu, P,
Olsen HS,
Gentz R,
and
Wagner GF.
Immunolocalization of stanniocalcin in human kidney.
Mol Cell Endocrinol
137:
155-159,
1998[ISI][Medline].
9.
De Niu, P,
Radman DP,
Jaworski EM,
Deol H,
Gentz R,
Su J,
Olsen HS,
and
Wagner GF.
Development of a human stanniocalcin radioimmunoassay: serum and tissue hormone levels and pharmacokinetics in the rat.
Mol Cell Endocrinol
162:
131-144,
2000[ISI][Medline].
10.
Deol, HK,
Varghese R,
Wagner GF,
and
Dimattia GE.
Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation.
Endocrinology
141:
3412-3421,
2000
11.
DiMattia, GE,
Varghese R,
and
Wagner GF.
Molecular cloning and characterization of stanniocalcin-related protein.
Mol Cell Endocrinol
146:
137-140,
1998[ISI][Medline].
12.
Ellis, TJ,
and
Wagner GF.
Post-transcriptional regulation of the stanniocalcin gene by calcium.
J Biol Chem
270:
1960-1965,
1995
13.
Flik, G,
Fenwick JC,
Kolar Z,
Mayer-Gostan N,
and
Wendelaar Bonga SE.
Effects of low ambient calcium levels on whole body Ca flux rates and internal calcium pools in the freshwater cichlid teleost (Oreochromis mossambicus).
J Exp Biol
120:
249-264,
1986[ISI].
14.
Franzen, AM,
Zhang KZ,
Westberg JA,
Zhang WM,
Arola J,
Olsen HS,
and
Andersson LC.
Expression of stanniocalcin in the epithelium of human choroid plexus.
Brain Res
887:
440-443,
2000[ISI][Medline].
15.
Fujiwara, Y,
Sugita Y,
Nakamori S,
Miyamoto A,
Shiozaki K,
Nagano H,
Sakon M,
and
Monden M.
Assessment of stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.
Int J Oncol
16:
799-804,
2000[ISI][Medline].
16.
Haddad, M,
Roder S,
Olsen HS,
and
Wagner GF.
Immunocytochemical localization of stanniocalcin cells in the rat kidney.
Endocrinology
137:
2113-2117,
1996[Abstract].
17.
Honda, S,
Kashiwagi M,
Ookata K,
Tojo A,
and
Hirose S.
Regulation by 1-,25-dihydroxyvitamin D3 of expression of stanniocalcin messages in the rat kidney and ovary.
FEBS Lett
459:
119-122,
1999[ISI][Medline].
18.
Hulova, I,
and
Kawauchi H.
Assignment of disulfide linkages in chum salmon stanniocalcin.
Biochem Biophys Res Commun
257:
295-299,
1999[ISI][Medline].
19.
Ishibashi, K,
Miyamoto K,
Taketani Y,
Morita K,
Takeda E,
Sasaki S,
and
Imai M.
Molecular cloning of a second human stanniocalcin homologue (STC2).
Biochem Biophys Res Commun
250:
252-258,
1998[ISI][Medline].
20.
Iyer, VR,
Eisen MB,
Ross DT,
Schuler G,
Moore T,
Lee JCF,
Trent JM,
Staudt LM,
Hudson J, Jr,
Boguski MS,
Lashkari D,
Shalon D,
Botstein D,
and
Brown PO.
The transcriptional program in the response of human fibroblasts to serum.
Science
283:
83-87,
1999
21.
Jellinek, DA,
Chang AC,
Larsen MR,
Wang X,
Robinson PJ,
and
Reddel RR.
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells.
Biochem J
350:
453-461,
2000[ISI][Medline].
22.
Jiang, WQ,
Chang AC,
Satoh M,
Furuichi Y,
Tam PP,
and
Reddel RR.
The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development.
J Endocrinol
165:
457-466,
2000
23.
Kahn, J,
Mehraban F,
Ingle G,
Xin X,
Bryant JE,
Vehar G,
Schoenfeld J,
Grimaldi CJ,
Peale F,
Draksharapu A,
Lewin DA,
and
Gerritsen ME.
Gene expression profiling in an in vitro model of angiogenesis.
Am J Pathol
156:
1887-1900,
2000
24.
Kaneko, T,
Hasegawa S,
and
Hirano T.
Embryonic origin and development of the corpuscles of Stannius in chum salmon (Oncorhynchus keta).
Cell Tissue Res
268:
65-70,
1992[ISI][Medline].
25.
Lu, M,
Wagner GF,
and
Renfro JL.
Stanniocalcin stimulates phosphate reabsorption by flounder renal proximal tubule in primary culture.
Am J Physiol Regulatory Integrative Comp Physiol
267:
R1356-R1362,
1994
26.
Madsen, KL,
Tavernini MM,
Yachimec C,
Mendrick DL,
Alfonso PJ,
Buergin M,
Olsen HS,
Antonaccio MJ,
Thomson AB,
and
Fedorak RN.
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine.
Am J Physiol Gastrointest Liver Physiol
274:
G96-G102,
1998
27.
Marra, LE,
Butler DG,
Zhang DH,
Oudit GY,
and
Youson JH.
Corpuscles of Stannius and stanniocalcin-like immunoreactivity in the white sucker (Catostomus commersoni): evidence for a new cell-type.
Cell Tissue Res
293:
155-164,
1998[ISI][Medline].
28.
Milet, C,
Buscaglia M,
Chartier MM,
Martelly E,
and
Lopez E.
Comparative effect of Stannius corpuscles extract and 1-34 hPTH in the anuran, Xenopus laevis (Abstract).
Gen Comp Endocrinol
53:
497,
1984[ISI].
29.
Miura, W,
Mizunashi K,
Kimura N,
Koide Y,
Noshiro T,
Miura Y,
Furukawa Y,
and
Nagura H.
Expression of stanniocalcin in zona glomerulosa and medulla of normal human adrenal glands, and some adrenal tumors and cell lines.
APMIS
108:
367-372,
2000[ISI][Medline].
30.
Moore, EE,
Kuestner RE,
Conklin DC,
Whitmore TE,
Downey W,
Buddle MM,
Adams RL,
Bell LA,
Thompson DL,
Wolf A,
Chen L,
Stamm MR,
Grant FJ,
Lok S,
Ren H,
and
De Jongh KS.
Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cells.
Horm Metab Res
31:
406-414,
1999[ISI][Medline].
31.
Morita, K,
Miyamoto K,
Ishibashi K,
Imai M,
Miyauchi A,
Taketani Y,
Yamamoto H,
and
Takeda E.
Molecular cloning and functional analysis of a second human stanniocalcin homologue (STC2).
J Bone Miner Res
14, Suppl1:
S210,
1999[ISI].
32.
Olsen, HS,
Cepeda MA,
Zhang QQ,
Rosen CA,
and
Vozzolo BL.
Human stanniocalcin: a possible hormonal regulator of mineral metabolism.
Proc Natl Acad Sci USA
93:
1792-1796,
1996
33.
Sato, N,
Kokame K,
Shimokado K,
Kato H,
and
Miyata T.
Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others.
J Biochem (Tokyo)
123:
1119-1126,
1998[Abstract].
34.
Sheikh-Hamad, D,
Rouse D,
and
Yang Y.
Regulation of stanniocalcin in MDCK cells by hypertonicity and extracellular calcium.
Am J Physiol Renal Physiol
278:
F417-F424,
2000
35.
Snell, RG,
MacMillan JC,
Cheadle JP,
Fenton I,
Lazarou LP,
Davies P,
MacDonald ME,
Gusella JF,
Harper PS,
and
Shaw DJ.
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
Nat Genet
4:
393-397,
1993[ISI][Medline].
36.
Srivastav, AK,
and
Swarup K.
Calcemic responses of Stannius corpuscles extract in parrots, Psittacula psittacula.
Experientia
38:
869-870,
1982[ISI][Medline].
37.
Stasko, SE,
and
Wagner GF.
Stanniocalcin gene expression during mouse urogenital development: a possible role in mesenchymal-epithelial signalling.
Dev Dyn
220:
49-59,
2001[ISI][Medline].
38.
Sundell, K,
Bjornsson BT,
Itoh H,
and
Kawauchi H.
Chum salmon (Oncorhynchus keta) stanniocalcin inhibits in vitro intestinal calcium uptake in Atlantic cod (Gadus morhua).
J Comp Physiol [B]
162:
489-495,
1992[ISI][Medline].
39.
Urasa, FM,
and
Wendelaar Bonga SE.
Stannius corpuscles and plasma calcium levels during the reproductive cycle in the cichild teleost fish, Oreochromis mossambicus.
Cell Tiss Res
241:
219-227,
1985[ISI][Medline].
40.
Van der Heijden, AJ,
Verbost PM,
Bijvelds MJ,
Atsma W,
Wendelaar Bonga SE,
and
Flik G.
Effects of sea water and stanniectomy on branchial Ca(2+) handling and drinking rate in eel (Anguilla anguilla L.).
J Exp Biol
202:
2505-2511,
1999
41.
Varghese, R,
Wong CK,
Deol H,
Wagner GF,
and
DiMattia GE.
Comparative analysis of mammalian stanniocalcin genes.
Endocrinology
139:
4714-4725,
1998
42.
Verbost, PM,
Flik G,
Fenwick JC,
Greco AM,
Pang PKT,
and
Wendelaar Bonga SE.
Branchial calcium uptake: possible mechanisms of control by stanniocalcin.
Fish Physiol Biochem
11:
205-215,
1993[ISI].
43.
Wagner, GF,
Guiraudon CC,
Milliken C,
and
Copp DH.
Immunological and biological evidence for a stanniocalcin-like hormone in human kidney.
Proc Natl Acad Sci USA
92:
1871-1875,
1995[Abstract].
44.
Wagner, GF,
Haddad M,
Fargher RC,
Milliken C,
and
Copp DH.
Calcium is an equipotent stimulator of stanniocalcin secretion in freshwater and seawater salmon.
Gen Comp Endocrinol
109:
186-191,
1998[ISI][Medline].
45.
Wagner, GF,
Jaworski EM,
and
Haddad M.
Stanniocalcin in the seawater salmon: structure, function, and regulation.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R1177-R1185,
1998
46.
Wagner, GF,
Vozzolo BL,
Jaworski E,
Haddad M,
Kline RL,
Olsen HS,
Rosen CA,
Davidson MB,
and
Renfro JL.
Human stanniocalcin inhibits renal phosphate excretion in the rat.
J Bone Miner Res
12:
165-171,
1997[ISI][Medline].
47.
White, KE,
Biber J,
Murer H,
and
Econs MJ.
Chromosomal localization of two human genes involved in phosphate homeostasis: the type IIb sodium-phosphate cotransporter and stanniocalcin-2.
Somat Cell Mol Genet
24:
357-362,
1998[Medline].
48.
Wong, CK,
Ho MA,
and
Wagner GF.
The co-localization of stanniocalcin protein, mRNA and kidney cell markers in the rat kidney.
J Endocrinol
158:
183-189,
1998
49.
Worthington, RA,
Brown L,
Jellinek D,
Chang AC,
Reddel RR,
Hambly BD,
and
Barden JA.
Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary.
Electrophoresis
20:
2071-2076,
1999[ISI][Medline].
50.
Yoshiko, Y,
Kosugi T,
and
Koide Y.
Effects of a synthetic N-terminal fragment of stanniocalcin on the metabolism of mammalian bone in vitro.
Biochim Biophys Acta
1311:
143-149,
1996[ISI][Medline].
51.
Yoshiko, Y,
and
Maeda N.
In situ hybridization analysis of stanniocalcin mRNA expressing cells in the mouse kidney.
Mol Cell Endocrinol
141:
37-40,
1998[ISI][Medline].
52.
Yoshiko, Y,
Son A,
Maeda S,
Igarashi A,
Takano S,
Hu J,
and
Maeda N.
Evidence for stanniocalcin gene expression in mammalian bone.
Endocrinology
140:
1869-1874,
1999
53.
Zhang, KZ,
Lindsberg PJ,
Tatlisumak T,
Kaste M,
Olsen HS,
and
Andersson LC.
Stanniocalcin: a molecular guard of neurons during cerebral ischemia.
Proc Natl Acad Sci USA
97:
3637-3642,
2000
54.
Zhang, KZ,
Westberg JA,
Paetau A,
von Boguslawsky K,
Lindsberg P,
Erlander M,
Guo H,
Su J,
Olsen HS,
and
Andersson LC.
High expression of stanniocalcin in differentiated brain neurons.
Am J Pathol
153:
439-445,
1998